MNKD

MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29

MNKD Stock Price Increases Over 7% Pre-Market: Why It Happened

MannKind and United Therapeutics Achieve a Major Milestone in the Development of Tyvaso DPI™ With New Drug Application Acceptance From the FDA

MannKind Corporation (MNKD) Management Presents at Lytham Partners Summer 2021 Investor Conference (Transcript)

MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Diseases

MannKind Corporation at the Lytham Partners Summer 2021 Investor Conference

MannKind Announces Data Presentation At 14th International Conference On Advanced Technologies & Treatments For Diabetes (ATTD 2021) To Be Held Virtually June 2-5